|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 46.84 EUR | +0.95% |
|
-8.87% | -4.51% |
| 10:20am | Bundestag to Decide on Amendments to Hospital Reform | DP |
| 04/03 | FRESENIUS SE : Barclays reiterates its Buy rating | ZD |
Company Valuation: Fresenius SE & Co. KGaA
Data adjusted to current consolidation scope
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 21,095 | 19,769 | 14,785 | 15,810 | 18,891 | 26,134 | 26,134 | - |
| Change | - | -6.28% | -25.21% | 6.93% | 19.49% | 38.34% | 0% | - |
| Enterprise Value (EV) 1 | 45,171 | 44,160 | 39,799 | 29,078 | 30,186 | 37,074 | 36,689 | 35,524 |
| Change | - | -2.24% | -9.88% | -26.94% | 3.81% | 22.82% | -1.04% | -3.18% |
| P/E ratio | 12.4x | 10.9x | 10.8x | -26.7x | 39.9x | 21.9x | 14.3x | 12.7x |
| PBR | 1.24x | 1.04x | 0.72x | 0.83x | 0.97x | 1.31x | 1.26x | 1.2x |
| PEG | - | 1.67x | -0.4x | 0x | -0x | 0x | 0.7x | 0.9x |
| Capitalization / Revenue | 0.58x | 0.53x | 0.36x | 0.71x | 0.87x | 1.21x | 1.11x | 1.05x |
| EV / Revenue | 1.25x | 1.18x | 0.97x | 1.3x | 1.38x | 1.65x | 1.55x | 1.43x |
| EV / EBITDA | 6.33x | 6.47x | 6.32x | 8.5x | 8.35x | 9.82x | 9.45x | 8.34x |
| EV / EBIT | 9.79x | 10.4x | 9.94x | 12.9x | 12.1x | 14.3x | 13.1x | 11.7x |
| EV / FCF | 18.2x | 37x | 17.4x | 8.75x | 20.3x | 29.1x | 23.7x | 20.1x |
| FCF Yield | 5.49% | 2.7% | 5.73% | 11.4% | 4.92% | 3.44% | 4.22% | 4.97% |
| Dividend per Share 2 | 0.88 | 0.92 | 0.92 | - | 1 | 1.104 | 1.121 | 1.254 |
| Rate of return | 2.33% | 2.6% | 3.5% | - | 2.98% | 2.38% | 2.42% | 2.7% |
| EPS 2 | 3.06 | 3.26 | 2.44 | -1.05 | 0.84 | 2.24 | 3.235 | 3.667 |
| Distribution rate | 28.8% | 28.2% | 37.7% | - | 119% | 41.3% | 34.7% | 34.2% |
| Net sales 1 | 36,277 | 37,520 | 40,840 | 22,299 | 21,833 | 22,873 | 23,640 | 24,810 |
| EBITDA 1 | 7,132 | 6,825 | 6,294 | 3,422 | 3,614 | 3,775 | 3,882 | 4,262 |
| EBIT 1 | 4,612 | 4,252 | 4,004 | 2,262 | 2,489 | 2,595 | 2,795 | 3,029 |
| Net income 1 | 1,707 | 1,818 | 1,372 | -594 | 471 | 1,264 | 1,804 | 2,082 |
| Net Debt 1 | 24,076 | 24,391 | 25,014 | 13,268 | 11,295 | 10,940 | 10,555 | 9,390 |
| Reference price 2 | 37.84 | 35.40 | 26.25 | 28.07 | 33.54 | 46.40 | 46.40 | 46.40 |
| Nbr of stocks (in thousands) | 5,57,472 | 5,58,454 | 5,63,237 | 5,63,237 | 5,63,237 | 5,63,237 | 5,63,237 | - |
| Announcement Date | 23/02/21 | 22/02/22 | 04/03/23 | 21/02/24 | 26/02/25 | 25/02/26 | - | - |
1EUR in Million2EUR
Estimates
P/E ratio, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 17.37x | 1.65x | 9.82x | 2.38% | 3.02TCr | ||
| 17.56x | 2.12x | 10.41x | 0.57% | 12TCr | ||
| 13.26x | 0.37x | 8.31x | 3.44% | 10TCr | ||
| 20.54x | 1.83x | 10.49x | 1.05% | 2.27TCr | ||
| 21.57x | 2.34x | 11.87x | 1.59% | 2.24TCr | ||
| 29.21x | 5.73x | 23.53x | 2.32% | 2.22TCr | ||
| 11.25x | 1.37x | 6.51x | -.--% | 2.1TCr | ||
| 16.18x | 1.48x | 7.46x | 4.53% | 1.59TCr | ||
| 12.22x | 0.96x | 5.3x | 3.64% | 1.26TCr | ||
| 8.47x | 0.88x | 6.01x | 0.42% | 1.2TCr | ||
| Average | 16.76x | 1.87x | 9.97x | 1.99% | 3.79TCr | |
| Weighted average by Cap. | 16.63x | 1.68x | 10.02x | 1.9% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Equities
- FRE Stock
- Valuation Fresenius SE & Co. KGaA
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















